DrugPatentWatch Database Preview
Mechanism of Action: Cytochrome P450 2D6 Inhibitors
» See Plans and Pricing
Drugs with Mechanism of Action: Cytochrome P450 2D6 Inhibitors
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Rising | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208371-001 | Feb 25, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Dr Reddys Labs Ltd | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208416-001 | May 18, 2020 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
Amneal Pharms | ABIRATERONE ACETATE | abiraterone acetate | TABLET;ORAL | 208327-001 | Jan 7, 2019 | AB | RX | No | No | Start Trial | Start Trial | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |